Dr. Ronald Warren Anderson, M.D., PH.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 407 S 19th St, Blair, NE 68008 Phone: 402-426-2210 Fax: 402-426-2235 |
News Archive
BIOTECHNICA, Europe's Leading Exhibition for Biotechnology and Life Sciences, is broadening its portfolio to include a new conference and special display on molecular diagnostics. Produced by the Cambridge Healthtech Institute, a leading organizer of biomedical conferences in the United States, the "Molecular Diagnostics Europe" (MDxEU) conference is making its debut this year. The main focus will be on new methods for molecular diagnostics, particularly with regard to cancer and infectious diseases.
Cholesterol-lowering medications in the statin class could significantly reduce the risk for developing open-angle glaucoma, show data for more than 500,000 older-age US individuals with hyperlipidemia.
InfoMedics, Inc., a company that engages patients and physicians to communicate better through the delivery of treatment feedback, has poster presentations at three industry conferences in October 2009. All of these studies provide a unique look at real-life patient feedback regarding experiences with medications for chronic conditions including ulcerative colitis (UC) and attention-deficit/hyperactivity disorder (ADHD) in adults and children.
Today Omron Healthcare, Inc., a leader in personal wellness products, launched its first-ever, continuous Strapless Heart Rate Monitor (HR-500U). Exercise enthusiasts can now take their workout to the next level comfortably without an annoying chest strap. Easy to use, the monitor is worn on the wrist and provides accurate, continuous monitoring.
A robotic system can safely assist interventional cardiologists in performing percutaneous coronary interventions (PCI) while significantly reducing the physician's exposure to radiation and improving precision and control, according to results of the PRECISE study (CorPath Percutaneous Robotically-Enhance Coronary Intervention Study), presented today as a late-breaking clinical trial at the SCAI 2012 Scientific Sessions.
› Verified 1 days ago